anidulafungin has been researched along with Mucorales Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E | 1 |
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E | 1 |
Edwards, JE; Fu, Y; Gebremariam, T; Ibrahim, AS; Spellberg, B | 1 |
1 review(s) available for anidulafungin and Mucorales Infection
Article | Year |
---|---|
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence | 2016 |
2 other study(ies) available for anidulafungin and Mucorales Infection
Article | Year |
---|---|
New pharmacological opportunities for the treatment of invasive mould diseases.
Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |
Combination echinocandin-polyene treatment of murine mucormycosis.
Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liposomes; Male; Micafungin; Mice; Mice, Inbred BALB C; Mucormycosis; Polyenes; Rhizopus; Treatment Outcome | 2008 |